Inhibition of NF-<i>κ</i>B by Dehydroxymethylepoxyquinomicin Suppresses Invasion and Synergistically Potentiates Temozolomide and <i>γ</i>-Radiation Cytotoxicity in Glioblastoma Cells

<table>Clonogenic survival assay of GBM cell lines irradiated with 2, 4 and 6 Gy (control) and cells pre-treated with 10 <i>μ</i>g/mL DHMEQ for 24 h before irradiation with the same doses. Treatment significantly radio-sensitized cells. Each value represents the mean derived from at least three individual experiments in duplicate (mean ± SD).</table>

Chemotherapy Research and Practice

fig7

Figure 7

Figure 7: Inhibition of NF-<i>κ</i>B by Dehydroxymethylepoxyquinomicin Suppresses Invasion and Synergistically Potentiates Temozolomide and <i>γ</i>-Radiation Cytotoxicity in Glioblastoma Cells 

Figure 7 | Inhibition of NF-κB by Dehydroxymethylepoxyquinomicin Suppresses Invasion and Synergistically Potentiates Temozolomide and γ-Radiation Cytotoxicity in Glioblastoma Cells 